Active Ingredient: MEDROXYPROGESTERONE ACETATE
Proprietary Name: MEDROXYPROGESTERONE ACETATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 150MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214309
Product Number: 001
Approval Date: Jan 5, 2023
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
